Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

The US FDA has granted full approval to Moderna’s COVID-19 vaccine Spikevax for use in children aged six months to 11 years ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA vaccines in particular.

Leading US medical associations have opened two separate lawsuits against the Trump administration in the hope of stopping the growing politicisation of key national health policy. In one lawsuit the ...

Medical associations representing hundreds of thousands of doctors and scientists are suing Health Secretary Robert F.

Commission president targeted over refusal to release messages related to Covid-19 vaccines and plans for huge defence ...